Ketones, SGLT2, HFrEF
Conditions: Type2diabetes; Heart Failure With Reduced Ejection Fraction Interventions: Drug: Empagliflozin 25 MG Oral Tablet; Drug: Placebo; Drug: Acipimox 250 Mg Oral Capsule Sponsors: The University of Texas Health Science Center at San Antonio; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Diabetes | Empagliflozin | Endocrinology | Heart | Heart Failure | Jardiance | Research | Science | SGLT2 Inhibitors | Texas University | Urology & Nephrology